Top articles 2012
1 = Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures.
Krauss, GL; Serratosa, JM; Villanueva, V; et al.
NEUROLOGY Volume: 78 Issue: 18 Pages: 1408-1415 Published: MAY 2012 Times Cited: 46 (from Web of Science Core Collection)
2 = Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Waters, PJ; McKeon, A; Leite, MI; et al.
NEUROLOGY Volume: 78 Issue: 9 Pages: 665-671 Published: FEB 2012
Times Cited: 44 (from Web of Science Core Collection)
3 ˄ Total daily physical activity and the risk of AD and cognitive decline in older adults. Buchman, AS; Boyle, PA; Yu, L; et al.
NEUROLOGY Volume: 78 Issue: 17 Pages: 1323-1329 Published: APR 2012 Times Cited: 42 (from Web of Science Core Collection)
4 v A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.
Richard, IH; McDermott, MP; Kurlan, R; et al.
NEUROLOGY Volume: 78 Issue: 16 Pages: 1229-1236 Published: APR 2012 Times Cited: 40 (from Web of Science Core Collection)
4 = Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial.
Coles, AJ; Fox, E; Vladic, A; et al.
NEUROLOGY Volume: 78 Issue: 14 Pages: 1069-1078 Published: APR 2012 Times Cited: 40 (from Web of Science Core Collection)
4 = β-Amyloid burden in healthy aging: regional distribution and cognitive consequences.
Rodrigue, KM; Kennedy, KM; Devous, MD, Sr.; et al.
NEUROLOGY Volume: 78 Issue: 6 Pages: 387-395 Published: FEB 2012
Times Cited: 40 (from Web of Science Core Collection)
4 ˄ Patterns of treatment response in newly diagnosed epilepsy.
Brodie, MJ; Barry, SJE; Bamagous, GA; et al.
NEUROLOGY Volume: 78 Issue: 20 Pages: 1548-1554 Published: MAY 2012 Times Cited: 40 (from Web of Science Core Collection)
4 ˄ Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.
Silberstein, SD; Holland, S; Freitag, F; et al.
NEUROLOGY Volume: 78 Issue: 17 Pages: 1337-1345 Published: APR 2012 Times Cited: 40 (from Web of Science Core Collection)
5 ˄ Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial
Coelho, T; Maia, LF; da Silva, AM; et al.
NEUROLOGY Volume: 79 Issue: 8 Pages: 785-792 Published: AUG 2012 Full Text Times Cited: 38 (from Web of Science Core Collection)
5 ˄ Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304.
French, Jacqueline A.; Krauss, Gregory L.; Biton, V; et al.
NEUROLOGY Volume: 79 Issue: 6 Pages: 589-596 Published: AUG 2012
Times Cited: 38 (from Web of Science Core Collection)
6 ˄ APOE modifies the association between Aβ load and cognition in cognitively normal older adults.
Kantarci, K; Lowe, V; Przybelski, SA; et al.
NEUROLOGY Volume: 78 Issue: 4 Pages: 232-240 Published: JAN 2012
Times Cited: 32 (from Web of Science Core Collection)
7 ˄ Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes.
Weaver, FM; Follett, KA; Stern, M; et al.
NEUROLOGY Volume: 79 Issue: 1 Pages: 55-65 Published: JUL 2012
Times Cited: 30 (from Web of Science Core Collection)
7 ˄ Cerebral microbleeds are associated with worse cognitive function: the Rotterdam Scan Study.
Poels, MMF; Ikram, MA; van der Lugt, A; et al.
NEUROLOGY Volume: 78 Issue: 5 Pages: 326-333 Published: JAN 2012
Times Cited: 30 (from Web of Science Core Collection)
7 ˄ Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort.
Schoonenboom, NSM; Reesink, FE; Verwey, NA; et al.
NEUROLOGY Volume: 78 Issue: 1 Pages: 47-54 Published: JAN 2012
Times Cited: 30 (from Web of Science Core Collection)
8 ˄ Neurodegenerative causes of death among retired National Football League players.
Lehman, EJ; Hein, MJ; Baron, SL; et al.
NEUROLOGY Volume: 79 Issue: 19 Pages: 1970-1974 Published: NOV 2012 Times Cited: 29 (from Web of Science Core Collection)
8 ˄ Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Hu, WT; Holtzman, DM; Fagan, AM.; et al.
NEUROLOGY Volume: 79 Issue: 9 Pages: 897-905 Published: AUG 2012
Times Cited: 29 (from Web of Science Core Collection)
9 ˄ Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition.
Chetelat, G; Villemagne, VL; Villain, N; et al.
NEUROLOGY Volume: 78 Issue: 7 Pages: 477-484 Published: FEB 2012
Times Cited: 28 (from Web of Science Core Collection)
9 ˄ Postmortem verification of MS cortical lesion detection with 3D DIR.
Seewann, A; Kooi, E-J; Roosendaal, SD; et al.
NEUROLOGY Volume: 78 Issue: 5 Pages: 302-308 Published: JAN 2012
Times Cited: 28 (from Web of Science Core Collection)
10 ˄ Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial.
Goodin, DS; Reder, AT; Ebers, GC; et al.
NEUROLOGY Volume: 78 Issue: 17 Pages: 1315-1322 Published: APR 2012 Times Cited: 27 (from Web of Science Core Collection)
10 ˄ Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial.
Newhouse, P; Kellar, K; Aisen, P; et al.
NEUROLOGY Volume: 78 Issue: 2 Pages: 91-101 Published: JAN 2012
Times Cited: 27 (from Web of Science Core Collection)
Top articles 2011
1 = Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria Polman, CH.; Reingold, SC; Banwell, B; et al.
ANNALS OF NEUROLOGY Volume: 69 Issue: 2 Pages: 292-302 Published: FEB 2011 Times Cited: 523 (from Web of Science)
A comment to this top article can be found here.
2 = Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS
Zivadinov, R; Marr, K; Cutter, G; et al.
NEUROLOGY Volume: 77 Issue: 2 Pages: 138-144 Published: JUL 2011
Times Cited: 83 (from Web of Science)
2 ˄ Responsive cortical stimulation for the treatment of medically intractable partial epilepsy
Morrell, MJ; RNS Syst Epilepsy Study Grp
NEUROLOGY Volume: 77 Issue: 13 Pages: 1295-1304 Published: SEP 2011
Times Cited: 83 (from Web of Science)
3 ˄ Sun exposure and vitamin D are independent risk factors for CNS demyelination Lucas, RM; Ponsonby, A-L; Dear, K; et al.
NEUROLOGY Volume: 76 Issue: 6 Pages: 540-548 Published: FEB 8 2011
Times Cited: 74 (from Web of Science)
4 ˄ Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy
French, JA.; Abou-Khalil, BW; Leroy, RF; et al. RESTORE 1 Study 301 Investigators NEUROLOGY Volume: 76 Issue: 18 Pages: 1555-1563 Published: MAY 2011
Times Cited: 64 (from Web of Science)
5 ˄ Screening for tumours in paraneoplastic syndromes: report of an EFNS task force Titulaer, MJ; Soffietti, R; Dalmau, J; et al.
EUROPEAN JOURNAL OF NEUROLOGY Volume: 18 Issue: 1 Pages: 19-E3 Published: JAN 2011
Times Cited: 61 (from Web of Science)
A comment to this top article can be found here.
5 ˄ Guidelines in practice: treatment of painful diabetic neuropathy
Bril, V.; England, J.; Franklin, G. M.; et al.
NEUROLOGY Volume: 76 Issue: 20 Pages: 1758-1765 Published: MAY 2011
Times Cited: 61 (from Web of Science)
6 ˄ Default mode network connectivity in stable vs progressive mild cognitive impairment
Petrella, JR; Sheldon, FC; Prince, SE; et al.
NEUROLOGY.; Volume 76 Issue:6: Pages: 511-7. FEB 8 2011
Times Cited: 57 (from Web of Science)
7 ˄ Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease
Li, J; Wang, YJ; Zhang, M; et al. Chongqing Ageing Study Grp
NEUROLOGY Volume: 76 Issue: 17 Pages: 1485-1491 Published: APR 2011
Times Cited: 54 (from Web of Science)
7 ˄ Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis
O’Connor, PW; Goodman, A; Kappos, L; et al.
NEUROLOGY Volume: 76 Issue: 22 Pages: 1858-1865 Published: MAY 2011
Times Cited: 54 (from Web of Science)
8 ˄ Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study.
Koivunen, J; Scheinin, N; Virta, JR; et al.
NEUROLOGY Volume: 76 Issue: 12 Pages: 1085-1090 Published: MAR 2011
Times Cited: 51 (from Web of Science Core Collection)
9 = Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Cortese, I; Chaudhry, V; So, YT; et al.
NEUROLOGY Volume: 76 Issue: 3 Pages: 294-300 Published: JAN 18 2011
Times Cited: 50 (from Web of Science)
9 ˄ Use of iboprofen and risk of Parkison disease
Gao, X; Chen, H; Schwarzschild, MA; et al.
NEUROLOGY Volume: 76 Issue: 10 Pages: 863-869 Published: MAR 2011
Times Cited: 50 (from Web of Science)
9 ˄ Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline.
Debette, S; Seshadri, S; Beiser, A; et al.
NEUROLOGY Volume: 77 Issue: 5 Pages: 461-468 Published: AUG 2011
Times Cited: 50 (from Web of Science Core Collection)
9 ˄ Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.
Dickerson, BC; Stoub, TR; Shah, RC; et al.
NEUROLOGY Volume: 76 Issue: 16 Pages: 1395-1402 Published: APR 2011
Times Cited: 50 (from Web of Science Core Collection)
9 ˄ Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Cortese, I.; Chaudhry, V.; So, Y. T.; et al.
NEUROLOGY Volume: 76 Issue: 3 Pages: 294-300 Published: JAN 18 2011
Times Cited: 50 (from Web of Science Core Collection)
10 ˄ Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy.
Vermersch, P; Kappos, L; Gold, R; et al.
NEUROLOGY Volume: 76 Issue: 20 Pages: 1697-1704 Published: MAY 2011
Times Cited: 46 (from Web of Science Core Collection)
10 ˄ Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI.
Geurts, JJG.; Roosendaal, SD; Calabrese, M; et al.
NEUROLOGY Volume: 76 Issue: 5 Pages: 418-424 Published: FEB 1 2011
Times Cited: 46 (from Web of Science Core Collection)
